<\/div> \n![\"\"](\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=ZH85215&Transmission_Id=202505192257PR_NEWS_ASPR_____ZH85215&DateId=20250519\")
"];
$("#dvExtra").html(content_array[0]);})();
"];
$("#dvExtra").html(content_array[0]);})();关于Gene Solutions<\/b> <\/p> \n
Gene Solutions 是一家亚洲跨国生物科技公司，在利用先进的人工智能 (AI) 和 ctDNA 技术提供创新癌症检测解决方案方面处于领先地位。公司与东南亚 4,500 多家医院和诊所合作，拥有一支由约 250 名生物学专家和技术人员组成的专业团队，员工总数达 700 人。<\/p> \n
Gene Solutions 已发表 50 多篇同行评审的论文，并开展了 50 多项多中心研究，其自主研发成果以及位于新加坡和越南的 CAP 认证的新一代测序 (NGS) 实验室备受认可。该公司将多维基因组学与AI驱动分析方法相结合，推动癌症诊疗模式的革新。<\/p> \n
参考文献<\/b> <\/p> \n
(1) GLOBOCAN 2020 – Global Cancer Observatory, Lung Cancer Statistics<\/p> \n
(2) Lam, D. C.-L.; Liam, C.-K.; Andarini, S.; Park, S.; Tan, D. S. W.; Singh, N.; Jang, S. H.; Vardhanabhuti, V.; Ramos, A. B.; Nakayama, T.; Nhung, N. V.; Ashizawa, K.; Chang, Y.-C.; Tscheikuna, J.; Van, C. C.; Chan, W. Y.; Lai, Y.-H.; Yang, P.-C. Lung Cancer Screening in Asia: An Expert Consensus Report. Journal of Thoracic Oncology 2023, 18 (10), 1303–1322.<\/p> \n
(3)数据来源：美国癌症协会(ACS)《2022癌症事实与数据》和《2021癌症事实与数据》；ACS网站；国际癌症研究机构网站。<\/p> \n
(4) Infante, M. V.; Cardillo, G. Lung Cancer Screening in Never-Smokers: Facts and Remaining Issues. Eur Respir J<\/i>2020<\/b>, 56<\/i> (5), 2002949.<\/p> \n
(5) Kim, R. Y. Insights Into Opportunistic Lung Cancer Screening for Individuals Who Have Never Smoked. JAMA Netw Open 2025, 8 (1), e2454009.<\/p> \n
(6) Loh, C. H.; Koh, P. W.; Ang, D. J. M.; Lee, W. C.; Chew, W. M.; Koh, J. M. K. Characteristics of Singapore Lung Cancer Patients Who Miss out on Lung Cancer Screening Recommendations. Singapore Medical Journal 2024, 65 (5), 279–287.<\/p> \n
(7) Kakinuma, R.; Muramatsu, Y.; Asamura, H.; Watanabe, S.; Kusumoto, M.; Tsuchida, T.; Kaneko, M.; Tsuta, K.; Maeshima, A. M.; Ishii, G.; Nagai, K.; Yamaji, T.; Matsuda, T.; Moriyama, N. Low-Dose CT Lung Cancer Screening in Never-Smokers and Smokers: Results of an Eight-Year Observational Study. Transl Lung Cancer Res 2020, 9 (1), 10–22.<\/p> \n
(8) Pinsky PF. Lung cancer screening with low-dose CT: a world-wide view. Transl Lung Cancer Res. 2018 Jun;7(3):234–242. doi: 10.21037\/ tlcr.2018.05.12<\/p> \n
(9)中华人民共和国国家卫生健康委员会。（2024年8月27日）。国家卫生健康委办公厅关于印发《肺癌筛查与早诊早治方案（2024年版）》的通知。医疗应急司。<\/p> \n
(10) Martin, M. D.; Kanne, J. P.; Broderick, L. S.; Kazerooni, E. A.; Meyer, C. A. Lung-RADS: Pushing the Limits. RadioGraphics 2017, 37 (7), 1975–1993.<\/p> \n
(11) Nguyen, et. al. (2025) Prospective validation study: a non-invasive circulating tumor DNA-based assay for<\/p> \n
(12) Nguyen, V. T. C., et al. (2025). Cost-effective shallow genome-wide sequencing for profiling plasma cfDNA signatures to enhance lung cancer detection. Future Oncology, 1–12.<\/p> \n
联系人：pr@genesolutions.com<\/a><\/p> \n<\/div> \n"];
$("#dvExtra").html(content_array[0]);})();